Nirmatrelvir–ritonavir might only be effective in elderly patients

alexandrossfakianakis shared this article with you from Inoreader Nirmatrelvir–ritonavir might only be effective in elderly patients via Journal of Medical Virology Abstract Nirmatrelvir-ritonavir is an effective and safe oral antiviral drug which have been shown to reduce the risk of progression to severe COVID-191. It received emergency use authorization from the United States Food and Drug Administration (FDA) in December, 2021. This article is protected by copyright. All rights reserved. View on Web

Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.